Records containing: Idiopathic Restless Legs Syndrome

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2014-09-25
  An Open-label Extension Trial to Investigate the Safety and Tolerability of Long-term Treatment With Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2014-06-05
  A Phase 3 Multi-Center, Placebo-Controlled, Double Blind, 3-Armed Parallel Group, Comparative Study of SPM 962 4.5 and 6.75 mg/Day to Investigate Superiority to Placebo in Patients With Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2014-04-25
  A Placebo-Controlled Study for SPM 962 in RLS Patients
• CLINICAL_TRIALS study record update · 2014-04-23
  An Open-label Long-term Extension Trial From Late Phase II of SPM 962 (243-07-003) in Patients With Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2012-09-28
  Non-Interventional Study (NIS) in Patients With Restless Legs Syndrome (RLS) to Assess the Effectiveness and Safety of Neupro® in Daily Practise
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-09-27
  Randomized, Double Blind, 12-Month Study Of Pregabalin In Subjects With Restless Legs Syndrome
• CLINICAL_TRIALS study record update · 2009-08-25
  A Randomised, Double-blind Study to Evaluate the Efficacy and Safety of Pramipexole at Fixed Doses of 0.25 mg, 0.5 mg, and 0.75 mg in Patients With Idiopathic Restless Legs Syndrome for 6 Weeks, Followed by a 46-week Open-label Long-term Study